Viral Reservoirs
News
There are no results message
Resources
Our Resource Library is a place to share documents, videos, and training resources about HIV and STBBI research and related topics.
-
Resource Categories
CTN+
This resource was produced in response to requests by community members, is intended for people living with HIV, front-line staff, and community members seeking information about the immune system and the potential HIV cure and immunotherapy strategies currently under investigation. Before outlining these main approaches, a brief overview of the immune system — and HIV’s…
Studies
The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.
-
CTNPT 038: The Gutsy Study
Fecal microbiota transplantation to reduce immune activation in ART-treated people living with HIV with low CD4/CD8 ratio
-
CTNPT 045: Immune Response to COVID-19 Vaccination in People with HIV
Vaccines in a Time of Dual Pandemic: COVID-19 Vaccine in People with HIV
-
CTN 257: Impact of HIV on mucosa
Impact of HIV infection and antiretroviral therapy on mucosal and systemic memory CD4 T cells
-
CTN 205: Valproic acid and HIV
Use of valproic acid to purge HIV from resting CD4+ memory cells: Trial results
-
CTNPT 004: Effects of HLA allele frequencies on HIV disease progression
Effects of HLA allele frequencies on HIV disease progression and viral load among newly diagnosed HIV infected individuals in Manitoba: Trial Results
-
CTNPT 020: Therapeutic HIV vaccine with early HAART treatment initiation
A pilot randomized, open label study to evaluate the effect of a therapeutic HIV vaccine consisting of PENNVAX®-GP (gag, pol, env) and INO-9012 DNA vaccine delivered via electroporation on reducing HIV viral reservoirs in infected individuals, who initiated therapy during the acute/early phase of infection
Publications
Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.